Physician Education: Bridging Clinical Research and Patient Care

HIV Screening: What's New and Why It's More Important Than Ever

Tuesday, October 20, 2015

1:00 PM (ET), 12:00 PM (CT), 11:00 AM (MT), 10:00 AM (PT)

Overview

Assessment of Needs

The IAS–USA offers this state-of-the-art activity as part of a nationwide continuing education (CME) effort for physicians on the evolving challenges of managing HIV disease. This webinar on HIV screening will include a discussion on the fourth generation HIV diagnostic test and recent data showing the substantial personal health and public health benefits conferred by identifying new cases of HIV infection.

Learning Objectives

On completion of this IAS–USA live activity, participants will be able to:

  • Describe the epidemiology of HIV infection
  • Describe the indications for HIV screening
  • Explain its rationale, benefits, and risks
  • Identify testing options and characteristics
  • Recognize barriers to implementation

Registration

Who Should Attend

This webinar is designed for physicians who are actively treating or will be treating patients with HIV infection.

This activity is also relevant for other practitioners, including nurse practitioners and other nursing professionals, physician assistants, and pharmacists.

Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.

Registration closes on Monday, October 19, 2015, 4:00 PM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at registration“at”iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved before the CME activity is delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 1.5 hours of continuing nursing education. 

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Pharmacy Credits

Accreditation Council for Pharmacy Education logo

Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.5 hours (0.15 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UAN # 0761-9999-15-281-L01-P

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors:

PLATINUM SUPPORTERS
Gilead Sciences, Inc
ViiV Healthcare

GOLD SUPPORTERS
Bristol-Myers Squibb
Janssen Therapeutics
Merck & Co, Inc

Additional support for select activity types in this national program is provided by:
AbbVie

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at registration“at”iasusa.org or 415-544-9400.

Presenter(s)

Webinar Link

You may view or share the archived recording for educational purposes, however, it is not available for CME credit.